miRNAs in SARS-CoV-2 Infection: An Update

Li, Q.; Guan, X.; Wu, P.; Wang, X.; Zhou, L.; Tong, Y.; Ren, R.; Leung, K.S.M.; Lau, E.H.Y.; Wong, J.Y.; Xing, X.; Xiang, N.; Wu, Y.; Li, C.; Chen, Q.; Li, D.; Liu, T.; Zhao, J.; Liu, M.; Tu, W.; Chen, C.; Jin, L.; Yang, R.; Wang, Q.; Zhou, S.; Wang, R.; Liu, H.; Luo, Y.; Liu, Y.; Shao, G.; Li, H.; Tao, Z.; Yang, Y.; Deng, Z.; Liu, B.; Ma, Z.; Zhang, Y.; Shi, G.; Lam, T.T.Y.; Wu, J.T.; Gao, G.F.; Cowling, B.J.; Yang, B.; Leung, G.M.; Feng, Z. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N. Engl. J. Med., 2020, 382(13), 1199-1207.
[http://dx.doi.org/10.1056/NEJMoa2001316] [PMID: 31995857]

Huang, C.; Wang, Y.; Li, X.; Ren, L.; Zhao, J.; Hu, Y.; Zhang, L.; Fan, G.; Xu, J.; Gu, X.; Cheng, Z.; Yu, T.; Xia, J.; Wei, Y.; Wu, W.; Xie, X.; Yin, W.; Li, H.; Liu, M.; Xiao, Y.; Gao, H.; Guo, L.; Xie, J.; Wang, G.; Jiang, R.; Gao, Z.; Jin, Q.; Wang, J.; Cao, B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet, 2020, 395(10223), 497-506.
[http://dx.doi.org/10.1016/S0140-6736(20)30183-5] [PMID: 31986264]

COVID-19 Map. Johns Hopkins coronavirus resource center., Available from: https://coronavirus.jhu.edu/map.html Accessed on 2022 Jan 13.

Cucinotta, D.; Vanelli, M. WHO declares COVID-19 a pandemic. Acta Biomed., 2020, 91(1), 157-160.
[PMID: 32191675]

Lu, R.; Zhao, X.; Li, J.; Niu, P.; Yang, B.; Wu, H.; Wang, W.; Song, H.; Huang, B.; Zhu, N.; Bi, Y.; Ma, X.; Zhan, F.; Wang, L.; Hu, T.; Zhou, H.; Hu, Z.; Zhou, W.; Zhao, L.; Chen, J.; Meng, Y.; Wang, J.; Lin, Y.; Yuan, J.; Xie, Z.; Ma, J.; Liu, W.J.; Wang, D.; Xu, W.; Holmes, E.C.; Gao, G.F.; Wu, G.; Chen, W.; Shi, W.; Tan, W. Genomic characterisation and epidemiology of 2019 novel coronavirus: Im-plications for virus origins and receptor binding. Lancet, 2020, 395(10224), 565-574.
[http://dx.doi.org/10.1016/S0140-6736(20)30251-8] [PMID: 32007145]

Nakagawa, S.; Miyazawa, T. Genome evolution of SARS-CoV-2 and its virological characteristics. Inflamm. Regen., 2020, 40(1), 17.
[http://dx.doi.org/10.1186/s41232-020-00126-7] [PMID: 32834891]

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species severe acute respiratory syndrome-related coronavirus: Classifying 2019-nCoV and naming it SARS-CoV-2. Nat. Microbiol., 2020, 5(4), 536-544.
[http://dx.doi.org/10.1038/s41564-020-0695-z] [PMID: 32123347]

Azhar, A.; Al-hosaini, K.; Khan, P.A.; Oanz, A.M.; Zia, Q.; Banawas, S. Promiscuous biological features of newly emerged SARS-CoV-2 facilitate its unrestrained outbreak: An update. Coronaviruses, 2021, 2(10), e170821191027.
[http://dx.doi.org/10.2174/2666796702666210202125638]

Xiong, X.; Qu, K.; Ciazynska, K.A.; Hosmillo, M.; Carter, A.P.; Ebrahimi, S.; Ke, Z.; Scheres, S.H.W.; Bergamaschi, L.; Grice, G.L.; Zhang, Y.; Nathan, J.A.; Baker, S.; James, L.C.; Baxendale, H.E.; Goodfellow, I.; Doffinger, R.; Briggs, J.A.G. A thermostable, closed SARS-CoV-2 spike protein trimer. Nat. Struct. Mol. Biol., 2020, 27(10), 934-941.
[http://dx.doi.org/10.1038/s41594-020-0478-5] [PMID: 32737467]

Shang, J.; Wan, Y.; Luo, C.; Ye, G.; Geng, Q.; Auerbach, A.; Li, F. Cell entry mechanisms of SARS-CoV-2. Proc. Natl. Acad. Sci. USA, 2020, 117(21), 11727-11734.
[http://dx.doi.org/10.1073/pnas.2003138117] [PMID: 32376634]

Yuan, Y.; Cao, D.; Zhang, Y.; Ma, J.; Qi, J.; Wang, Q.; Lu, G.; Wu, Y.; Yan, J.; Shi, Y.; Zhang, X.; Gao, G.F. Cryo-EM structures of MERS-CoV and SARS-CoV spike glycoproteins reveal the dynamic receptor binding domains. Nat. Commun., 2017, 8(1), 15092.
[http://dx.doi.org/10.1038/ncomms15092] [PMID: 28393837]

Gui, M.; Song, W.; Zhou, H.; Xu, J.; Chen, S.; Xiang, Y.; Wang, X. Cryo-electron microscopy structures of the SARS-CoV spike glycopro-tein reveal a prerequisite conformational state for receptor binding. Cell Res., 2017, 27(1), 119-129.
[http://dx.doi.org/10.1038/cr.2016.152] [PMID: 28008928]

Lu, S.; Ye, Q.; Singh, D.; Cao, Y.; Diedrich, J.K.; Yates, J.R., III; Villa, E.; Cleveland, D.W.; Corbett, K.D. The SARS-CoV-2 nucleocapsid phosphoprotein forms mutually exclusive condensates with RNA and the membrane-associated M protein. Nat. Commun., 2021, 12(1), 502.
[http://dx.doi.org/10.1038/s41467-020-20768-y] [PMID: 33479198]

Walls, A.C.; Park, Y-J.; Tortorici, M.A.; Wall, A.; McGuire, A.T.; Veesler, D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell, 2020, 181(2), 281-292.e6.
[http://dx.doi.org/10.1016/j.cell.2020.02.058] [PMID: 32155444]

Ratti, M.; Lampis, A.; Ghidini, M.; Salati, M.; Mirchev, M.B.; Valeri, N.; Hahne, J.C. MicroRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: First steps from bench to bedside. Target. Oncol., 2020, 15(3), 261-278.
[http://dx.doi.org/10.1007/s11523-020-00717-x] [PMID: 32451752]

Hum, C.; Loiselle, J.; Ahmed, N.; Shaw, T.A.; Toudic, C.; Pezacki, J.P. MicroRNA mimics or inhibitors as antiviral therapeutic approaches against COVID-19. Drugs, 2021, 81(5), 517-531.
[http://dx.doi.org/10.1007/s40265-021-01474-5] [PMID: 33638807]

El-Nabi, S.H.; Elhiti, M.; El-Sheekh, M. A new approach for COVID-19 treatment by micro-RNA. Med. Hypotheses, 2020, 143, 110203.
[http://dx.doi.org/10.1016/j.mehy.2020.110203] [PMID: 33017912]

Gasparello, J.; Finotti, A.; Gambari, R. Tackling the COVID-19 “cytokine storm” with microRNA mimics directly targeting the 3'UTR of pro-inflammatory mRNAs. Med. Hypotheses, 2021, 146, 110415.
[http://dx.doi.org/10.1016/j.mehy.2020.110415] [PMID: 33422363]

Farr, R.J.; Rootes, C.L.; Rowntree, L.C.; Nguyen, T.H.O.; Hensen, L.; Kedzierski, L.; Cheng, A.C.; Kedzierska, K.; Au, G.G.; Marsh, G.A.; Vasan, S.S.; Foo, C.H.; Cowled, C.; Stewart, C.R. Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection. PLoS Pathog., 2021, 17(7), e1009759.
[http://dx.doi.org/10.1371/journal.ppat.1009759] [PMID: 34320031]

Barbu, M.G.; Condrat, C.E.; Thompson, D.C.; Bugnar, O.L.; Cretoiu, D.; Toader, O.D.; Suciu, N.; Voinea, S.C. MicroRNA Involvement in signaling pathways during viral infection. Front. Cell Dev. Biol., 2020, 8, 143.
[http://dx.doi.org/10.3389/fcell.2020.00143] [PMID: 32211411]

Demongeot, J.; Seligmann, H. SARS-CoV-2 and miRNA-like inhibition power. Med. Hypotheses, 2020, 144, 110245.
[http://dx.doi.org/10.1016/j.mehy.2020.110245] [PMID: 33254550]

Siordia, J.A. Jr Epidemiology and clinical features of COVID-19: A review of current literature. J. Clin. Virol., 2020, 127, 104357.
[http://dx.doi.org/10.1016/j.jcv.2020.104357] [PMID: 32305884]

Woods, J.A.; Hutchinson, N.T.; Powers, S.K.; Roberts, W.O.; Gomez-Cabrera, M.C.; Radak, Z.; Berkes, I.; Boros, A.; Boldogh, I.; Leeu-wenburgh, C.; Coelho-Júnior, H.J.; Marzetti, E.; Cheng, Y.; Liu, J.; Durstine, J.L.; Sun, J.; Ji, L.L. The COVID-19 pandemic and physical activity. Sports Med. Health Sci., 2020, 2(2), 55-64.
[http://dx.doi.org/10.1016/j.smhs.2020.05.006] [PMID: 34189484]

AlAjmi, M.F.; Azhar, A.; Owais, M.; Rashid, S.; Hasan, S.; Hussain, A.; Rehman, M.T. Antiviral potential of some novel structural analogs of standard drugs repurposed for the treatment of COVID-19. J. Biomol. Struct. Dyn., 2021, 39(17), 6676-6688.
[http://dx.doi.org/10.1080/07391102.2020.1799865] [PMID: 32729392]

Borse, S.; Joshi, M.; Saggam, A.; Bhat, V.; Walia, S.; Marathe, A.; Sagar, S.; Chavan-Gautam, P.; Girme, A.; Hingorani, L.; Tillu, G. Ayur-veda botanicals in COVID-19 management: An in silico multi-target approach. PLoS One, 2021, 16(6), e0248479.
[http://dx.doi.org/10.1371/journal.pone.0248479] [PMID: 34115763]

AlAjmi, M.; Azhar, A.; Hasan, S.; Alshabr, A.; Hussain, A.; Rehman, T. Identification of natural compounds (proanthocyanidin and rhapontin) as high-affinity inhibitor of SARS-CoV-2 Mpro and PLpro using computational strategies. Arch. Med. Sci., 2021.
[http://dx.doi.org/10.5114/aoms/133706]

Facciolà, A.; Laganà, P.; Caruso, G. The COVID-19 pandemic and its implications on the environment. Environ. Res., 2021, 201, 111648.
[http://dx.doi.org/10.1016/j.envres.2021.111648] [PMID: 34242676]

Zambrano-Monserrate, M.A.; Ruano, M.A.; Sanchez-Alcalde, L. Indirect effects of COVID-19 on the environment. Sci. Total Environ., 2020, 728, 138813.
[http://dx.doi.org/10.1016/j.scitotenv.2020.138813] [PMID: 32334159]

Jackson, C.B.; Farzan, M.; Chen, B.; Choe, H. Mechanisms of SARS-CoV-2 entry into cells. Nat. Rev. Mol. Cell Biol., 2022, 23(1), 3-20.
[PMID: 34611326]

Cevik, M.; Kuppalli, K.; Kindrachuk, J.; Peiris, M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ, 2020, 371, m3862.
[http://dx.doi.org/10.1136/bmj.m3862] [PMID: 33097561]

Mirzaei, R.; Mahdavi, F.; Badrzadeh, F.; Hosseini-Fard, S.R.; Heidary, M.; Jeda, A.S.; Mohammadi, T.; Roshani, M.; Yousefimashouf, R.; Keyvani, H.; Darvishmotevalli, M.; Sani, M.Z.; Karampoor, S. The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Int. Immunopharmacol., 2021, 90, 107204.
[http://dx.doi.org/10.1016/j.intimp.2020.107204] [PMID: 33221169]

López, P.; Girardi, E.; Pfeffer, S. Importance of cellular microRNAs in the regulation of viral infections. Med. Sci. (Paris), 2019, 35(8-9), 667-673.
[PMID: 31532379]

Khan, A.A-K.; Sany, R.U.; Islam, S.; Islam, A.B.M.K. Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19. Front. Genet., 2020, 11, 765.
[http://dx.doi.org/10.3389/fgene.2020.00765] [PMID: 32765592]

Trobaugh, D.W.; Gardner, C.L.; Sun, C.; Haddow, A.D.; Wang, E.; Chapnik, E.; Mildner, A.; Weaver, S.C.; Ryman, K.D.; Klimstra, W.B. RNA viruses can hijack vertebrate microRNAs to suppress innate immunity. Nature, 2014, 506(7487), 245-248.
[http://dx.doi.org/10.1038/nature12869] [PMID: 24352241]

Scheel, T.K.H.; Luna, J.M.; Liniger, M.; Nishiuchi, E.; Rozen-Gagnon, K.; Shlomai, A.; Auray, G.; Gerber, M.; Fak, J.; Keller, I.; Brug-gmann, R.; Darnell, R.B.; Ruggli, N.; Rice, C.M. A broad RNA virus survey reveals both mIRNA dependence and functional sequestration. Cell Host Microbe, 2016, 19(3), 409-423.
[http://dx.doi.org/10.1016/j.chom.2016.02.007] [PMID: 26962949]

Fu, Z.; Wang, J.; Wang, Z.; Sun, Y.; Wu, J.; Zhang, Y.; Liu, X.; Zhou, Z.; Zhou, L.; Zhang, C.Y.; Yi, Y.; Xia, X.; Wang, L.; Chen, X. A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing se-vere disease. Cell Discov., 2021, 7(1), 48.
[http://dx.doi.org/10.1038/s41421-021-00289-8] [PMID: 34226530]

Lee, R.C.; Feinbaum, R.L.; Ambros, V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993, 75(5), 843-854.
[http://dx.doi.org/10.1016/0092-8674(93)90529-Y] [PMID: 8252621]

Wightman, B.; Ha, I.; Ruvkun, G. Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern for-mation in C. elegans. Cell, 1993, 75(5), 855-862.
[http://dx.doi.org/10.1016/0092-8674(93)90530-4] [PMID: 8252622]

Reinhart, B.J.; Slack, F.J.; Basson, M.; Pasquinelli, A.E.; Bettinger, J.C.; Rougvie, A.E.; Horvitz, H.R.; Ruvkun, G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature, 2000, 403(6772), 901-906.
[http://dx.doi.org/10.1038/35002607] [PMID: 10706289]

Slack, F.J.; Basson, M.; Liu, Z.; Ambros, V.; Horvitz, H.R.; Ruvkun, G. The lin-41 RBCC gene acts in the C. elegans heterochronic path-way between the let-7 regulatory RNA and the LIN-29 transcription factor. Mol. Cell, 2000, 5(4), 659-669.
[http://dx.doi.org/10.1016/S1097-2765(00)80245-2] [PMID: 10882102]

Pasquinelli, A.E.; Reinhart, B.J.; Slack, F.; Martindale, M.Q.; Kuroda, M.I.; Maller, B.; Hayward, D.C.; Ball, E.E.; Degnan, B.; Müller, P.; Spring, J.; Srinivasan, A.; Fishman, M.; Finnerty, J.; Corbo, J.; Levine, M.; Leahy, P.; Davidson, E.; Ruvkun, G. Conservation of the se-quence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 2000, 408(6808), 86-89.
[http://dx.doi.org/10.1038/35040556] [PMID: 11081512]

Li, F. Structure, function, and evolution of coronavirus spike proteins. Annu. Rev. Virol., 2016, 3(1), 237-261.
[http://dx.doi.org/10.1146/annurev-virology-110615-042301] [PMID: 27578435]

Perlman, S.; Netland, J. Coronaviruses post-SARS: Update on replication and pathogenesis. Nat. Rev. Microbiol., 2009, 7(6), 439-450.
[http://dx.doi.org/10.1038/nrmicro2147] [PMID: 19430490]

Zhang, Q.; Xiang, R.; Huo, S.; Zhou, Y.; Jiang, S.; Wang, Q.; Yu, F. Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy. Signal Transduct. Target. Ther., 2021, 6(1), 233.
[http://dx.doi.org/10.1038/s41392-021-00653-w] [PMID: 34117216]

Gomes, C.P.; Fernandes, D.E.; Casimiro, F.; da Mata, G.F.; Passos, M.T.; Varela, P.; Mastroianni-Kirsztajn, G.; Pesquero, J.B. Cathepsin L in COVID-19: From pharmacological evidences to genetics. Front. Cell. Infect. Microbiol., 2020, 10, 589505.
[http://dx.doi.org/10.3389/fcimb.2020.589505] [PMID: 33364201]

Wu, H-Y.; Brian, D.A. Subgenomic messenger RNA amplification in coronaviruses. Proc. Natl. Acad. Sci. USA, 2010, 107(27), 12257-12262.
[http://dx.doi.org/10.1073/pnas.1000378107] [PMID: 20562343]

Cullen, B.R. Transcription and processing of human microRNA precursors. Mol. Cell, 2004, 16(6), 861-865.
[http://dx.doi.org/10.1016/j.molcel.2004.12.002] [PMID: 15610730]

Zeng, Y.; Cullen, B.R. Efficient processing of primary microRNA hairpins by Drosha requires flanking nonstructured RNA sequences. J. Biol. Chem., 2005, 280(30), 27595-27603.
[http://dx.doi.org/10.1074/jbc.M504714200] [PMID: 15932881]

Chendrimada, T.P.; Gregory, R.I.; Kumaraswamy, E.; Norman, J.; Cooch, N.; Nishikura, K.; Shiekhattar, R. TRBP recruits the dicer com-plex to Ago2 for microRNA processing and gene silencing. Nature, 2005, 436(7051), 740-744.
[http://dx.doi.org/10.1038/nature03868] [PMID: 15973356]

Hutvágner, G.; McLachlan, J.; Pasquinelli, A.E.; Bálint, E.; Tuschl, T.; Zamore, P.D. A cellular function for the RNA-interference enzyme dicer in the maturation of the let-7 small temporal RNA. Science, 2001, 293(5531), 834-838.
[http://dx.doi.org/10.1126/science.1062961] [PMID: 11452083]

Henzinger, H.; Barth, D.A.; Klec, C.; Pichler, M. Non-Coding RNAs and SARS-related coronaviruses. Viruses, 2020, 12(12), E1374.
[http://dx.doi.org/10.3390/v12121374] [PMID: 33271762]

Singaravelu, R.; Nasheri, N.; Sherratt, A.; Pezacki, J.P. Systems biology methods help develop a better understanding of hepatitis C virus-induced liver injury. Hepatology, 2012, 56(1), 1-4.
[http://dx.doi.org/10.1002/hep.25727] [PMID: 22430896]

Singaravelu, R.; Chen, R.; Lyn, R.K.; Jones, D.M.; O’Hara, S.; Rouleau, Y.; Cheng, J.; Srinivasan, P.; Nasheri, N.; Russell, R.S.; Tyrrell, D.L.; Pezacki, J.P. Hepatitis C virus induced up-regulation of microRNA-27: A novel mechanism for hepatic steatosis. Hepatology, 2014, 59(1), 98-108.
[http://dx.doi.org/10.1002/hep.26634] [PMID: 23897856]

Yin, Q.; McBride, J.; Fewell, C.; Lacey, M.; Wang, X.; Lin, Z.; Cameron, J.; Flemington, E.K. MicroRNA-155 is an epstein-barr virus-induced gene that modulates epstein-barr virus-regulated gene expression pathways. J. Virol., 2008, 82(11), 5295-5306.
[http://dx.doi.org/10.1128/JVI.02380-07] [PMID: 18367535]

Girardi, E.; López, P.; Pfeffer, S. On the importance of host MicroRNAs during viral infection. Front. Genet., 2018, 9, 439.
[http://dx.doi.org/10.3389/fgene.2018.00439] [PMID: 30333857]

McCaskill, J.L.; Ressel, S.; Alber, A.; Redford, J.; Power, U.F.; Schwarze, J.; Dutia, B.M.; Buck, A.H. Broad-spectrum inhibition of res-piratory virus infection by MicroRNA mimics targeting p38 MAPK signaling. Mol. Ther. Nucleic Acids, 2017, 7, 256-266.
[http://dx.doi.org/10.1016/j.omtn.2017.03.008] [PMID: 28624201]

Luig, C.; Köther, K.; Dudek, S.E.; Gaestel, M.; Hiscott, J.; Wixler, V.; Ludwig, S. MAP kinase-activated protein kinases 2 and 3 are re-quired for influenza A virus propagation and act via inhibition of PKR. FASEB J., 2010, 24(10), 4068-4077.
[http://dx.doi.org/10.1096/fj.10-158766] [PMID: 20484669]

Marchant, D.; Singhera, G.K.; Utokaparch, S.; Hackett, T.L.; Boyd, J.H.; Luo, Z.; Si, X.; Dorscheid, D.R.; McManus, B.M.; Hegele, R.G. Toll-like receptor 4-mediated activation of p38 mitogen-activated protein kinase is a determinant of respiratory virus entry and tropism. J. Virol., 2010, 84(21), 11359-11373.
[http://dx.doi.org/10.1128/JVI.00804-10] [PMID: 20702616]

Ameling, S.; Kacprowski, T.; Chilukoti, R.K.; Malsch, C.; Liebscher, V.; Suhre, K.; Pietzner, M.; Friedrich, N.; Homuth, G.; Hammer, E.; Völker, U. Associations of circulating plasma microRNAs with age, body mass index and sex in a population-based study. BMC Med. Genomics, 2015, 8(1), 61.
[http://dx.doi.org/10.1186/s12920-015-0136-7] [PMID: 26462558]

Hewel, C.; Kaiser, J.; Wierczeiko, A.; Linke, J.; Reinhardt, C.; Endres, K.; Gerber, S. Common miRNA Patterns of Alzheimer’s Disease and Parkinson’s disease and their putative impact on commensal gut microbiota. Front. Neurosci., 2019, 13, 113.
[http://dx.doi.org/10.3389/fnins.2019.00113] [PMID: 30890906]

Nigi, L.; Grieco, G.E.; Ventriglia, G.; Brusco, N.; Mancarella, F.; Formichi, C.; Dotta, F.; Sebastiani, G. MicroRNAs as regulators of insulin signaling: Research updates and potential therapeutic perspectives in type 2 diabetes. Int. J. Mol. Sci., 2018, 19(12), E3705.
[http://dx.doi.org/10.3390/ijms19123705] [PMID: 30469501]

Daoud, A.Z.; Mulholland, E.J.; Cole, G.; McCarthy, H.O. MicroRNAs in pancreatic cancer: Biomarkers, prognostic, and therapeutic modu-lators. BMC Cancer, 2019, 19(1), 1130.
[http://dx.doi.org/10.1186/s12885-019-6284-y] [PMID: 31752758]

Guterres, A.; de Azeredo Lima, C.H.; Miranda, R.L.; Gadelha, M.R. What is the potential function of microRNAs as biomarkers and thera-peutic targets in COVID-19? Infect. Genet. Evol., 2020, 85, 104417.
[http://dx.doi.org/10.1016/j.meegid.2020.104417] [PMID: 32526370]

Li, C.; Hu, X.; Li, L.; Li, J-H. Differential microRNA expression in the peripheral blood from human patients with COVID-19. J. Clin. Lab. Anal., 2020, 34(10), e23590.
[http://dx.doi.org/10.1002/jcla.23590] [PMID: 32960473]

Tang, H.; Gao, Y.; Li, Z.; Miao, Y.; Huang, Z.; Liu, X.; Xie, L.; Li, H.; Wen, W.; Zheng, Y.; Su, W. The noncoding and coding transcrip-tional landscape of the peripheral immune response in patients with COVID-19. Clin. Transl. Med., 2020, 10(6), e200.
[http://dx.doi.org/10.1002/ctm2.200] [PMID: 33135345]

Boldin, M.P.; Taganov, K.D.; Rao, D.S.; Yang, L.; Zhao, J.L.; Kalwani, M.; Garcia-Flores, Y.; Luong, M.; Devrekanli, A.; Xu, J.; Sun, G.; Tay, J.; Linsley, P.S.; Baltimore, D. miR-146a is a significant brake on autoimmunity, myeloproliferation, and cancer in mice. J. Exp. Med., 2011, 208(6), 1189-1201.
[http://dx.doi.org/10.1084/jem.20101823] [PMID: 21555486]

Saha, A.; Bhagyawant, S.S.; Parida, M.; Dash, P.K. Vector-delivered artificial miRNA effectively inhibited replication of Chikungunya virus. Antiviral Res., 2016, 134, 42-49.
[http://dx.doi.org/10.1016/j.antiviral.2016.08.019] [PMID: 27565991]

Roviello, V.; Musumeci, D.; Mokhir, A.; Roviello, G.N. Evidence of protein binding by a nucleopeptide based on a thyminedecorated L-diaminopropanoic acid through CD and in silico studies. Curr. Med. Chem., 2021, 28(24), 5004-5015.
[http://dx.doi.org/10.2174/0929867328666210201152326] [PMID: 33593247]

Kaur, T.; Kapila, S.; Kapila, R.; Kumar, S.; Upadhyay, D.; Kaur, M.; Sharma, C. Tmprss2 specific miRNAs as promising regulators for SARS-CoV-2 entry checkpoint. Virus Res., 2021, 294, 198275.
[http://dx.doi.org/10.1016/j.virusres.2020.198275] [PMID: 33359190]

Saçar Demirci, M.D.; Adan, A. Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection. PeerJ, 2020, 8, e9369.
[http://dx.doi.org/10.7717/peerj.9369] [PMID: 32547891]

Głobińska, A.; Pawełczyk, M.; Kowalski, M.L. MicroRNAs and the immune response to respiratory virus infections. Expert Rev. Clin. Immunol., 2014, 10(7), 963-971.
[http://dx.doi.org/10.1586/1744666X.2014.913482] [PMID: 24784476]

Zhou, T.; Garcia, J.G.N.; Zhang, W. Integrating microRNAs into a system biology approach to acute lung injury. Transl. Res., 2011, 157(4), 180-190.
[http://dx.doi.org/10.1016/j.trsl.2011.01.010] [PMID: 21420028]

Riess, M.; Fuchs, N.V.; Idica, A.; Hamdorf, M.; Flory, E.; Pedersen, I.M.; König, R. Interferons induce expression of SAMHD1 in mono-cytes through down-regulation of miR-181a and miR-30a. J. Biol. Chem., 2017, 292(1), 264-277.
[http://dx.doi.org/10.1074/jbc.M116.752584] [PMID: 27909056]

Jiang, S.; Li, C.; Olive, V.; Lykken, E.; Feng, F.; Sevilla, J.; Wan, Y.; He, L.; Li, Q.J. Molecular dissection of the miR-17-92 cluster’s criti-cal dual roles in promoting Th1 responses and preventing inducible Treg differentiation. Blood, 2011, 118(20), 5487-5497.
[http://dx.doi.org/10.1182/blood-2011-05-355644] [PMID: 21972292]

Anglicheau, D.; Muthukumar, T.; Suthanthiran, M. MicroRNAs: Small RNAs with big effects. Transplantation, 2010, 90(2), 105-112.
[http://dx.doi.org/10.1097/TP.0b013e3181e913c2] [PMID: 20574417]

Sonkoly, E.; Ståhle, M.; Pivarcsi, A. MicroRNAs and immunity: Novel players in the regulation of normal immune function and inflam-mation. Semin. Cancer Biol., 2008, 18(2), 131-140.
[http://dx.doi.org/10.1016/j.semcancer.2008.01.005] [PMID: 18291670]

Li, Q-J.; Chau, J.; Ebert, P.J.R.; Sylvester, G.; Min, H.; Liu, G.; Braich, R.; Manoharan, M.; Soutschek, J.; Skare, P.; Klein, L.O.; Davis, M.M.; Chen, C.Z. miR-181a is an intrinsic modulator of T cell sensitivity and selection. Cell, 2007, 129(1), 147-161.
[http://dx.doi.org/10.1016/j.cell.2007.03.008] [PMID: 17382377]

Wang, C.; Chen, T.; Zhang, J.; Yang, M.; Li, N.; Xu, X.; Cao, X. The E3 ubiquitin ligase Nrdp1 ‘preferentially’ promotes TLR-mediated production of type I interferon. Nat. Immunol., 2009, 10(7), 744-752.
[http://dx.doi.org/10.1038/ni.1742] [PMID: 19483718]

An, H.; Hou, J.; Zhou, J.; Zhao, W.; Xu, H.; Zheng, Y.; Yu, Y.; Liu, S.; Cao, X. Phosphatase SHP-1 promotes TLR- and RIG-I-activated production of type I interferon by inhibiting the kinase IRAK1. Nat. Immunol., 2008, 9(5), 542-550.
[http://dx.doi.org/10.1038/ni.1604] [PMID: 18391954]

Yang, P.; An, H.; Liu, X.; Wen, M.; Zheng, Y.; Rui, Y.; Cao, X. The cytosolic nucleic acid sensor LRRFIP1 mediates the production of type I interferon via a beta-catenin-dependent pathway. Nat. Immunol., 2010, 11(6), 487-494.
[http://dx.doi.org/10.1038/ni.1876] [PMID: 20453844]

Pedersen, I.M.; Cheng, G.; Wieland, S.; Volinia, S.; Croce, C.M.; Chisari, F.V.; David, M. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature, 2007, 449(7164), 919-922.
[http://dx.doi.org/10.1038/nature06205] [PMID: 17943132]

Sodroski, C.; Lowey, B.; Hertz, L.; Jake Liang, T.; Li, Q. MicroRNA-135a modulates hepatitis C virus genome replication through down-regulation of host antiviral factors. Virol. Sin., 2019, 34(2), 197-210.
[http://dx.doi.org/10.1007/s12250-018-0055-9] [PMID: 30456659]

Netea, M.G.; Domínguez-Andrés, J.; Barreiro, L.B.; Chavakis, T.; Divangahi, M.; Fuchs, E.; Joosten, L.A.B.; van der Meer, J.W.M.; Mhlanga, M.M.; Mulder, W.J.M.; Riksen, N.P.; Schlitzer, A.; Schultze, J.L.; Stabell Benn, C.; Sun, J.C.; Xavier, R.J.; Latz, E. Defining trained immunity and its role in health and disease. Nat. Rev. Immunol., 2020, 20(6), 375-388.
[http://dx.doi.org/10.1038/s41577-020-0285-6] [PMID: 32132681]

Azhar, A.; Hassan, N.; Singh, M.; Al-Hosaini, K.; Kamal, M.A. Synopsis of pharmotechnological approaches in diagnostic and manage-ment strategies for fighting against COVID-19. Curr. Pharm. Des., 2021, 27(39), 4086-4099.
[http://dx.doi.org/10.2174/1381612827666210715154004] [PMID: 34269664]

Chauhan, N.; Jaggi, M.; Chauhan, S.C.; Yallapu, M.M. COVID-19: Fighting the invisible enemy with microRNAs. Expert Rev. Anti Infect. Ther., 2021, 19(2), 137-145.
[http://dx.doi.org/10.1080/14787210.2020.1812385] [PMID: 32814446]

Arora, S.; Singh, P.; Dohare, R.; Jha, R.; Ali Syed, M. Unravelling host-pathogen interactions: CeRNA network in SARS-CoV-2 infection (COVID-19). Gene, 2020, 762, 145057.
[http://dx.doi.org/10.1016/j.gene.2020.145057] [PMID: 32805314]

Liu, Z.; Wang, J.; Xu, Y.; Guo, M.; Mi, K.; Xu, R. Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2. ArXiv200404874 Q-Bio 2020.

Sardar, R.; Satish, D.; Birla, S.; Gupta, D. Integrative analyses of SARS-CoV-2 genomes from different geographical locations reveal unique features potentially consequential to host-virus interaction, pathogenesis and clues for novel therapies. Heliyon, 2020, 6(9), e04658.
[http://dx.doi.org/10.1016/j.heliyon.2020.e04658] [PMID: 32844125]

Hosseini Rad Sm, A.; McLellan, A.D. Implications of SARS-CoV-2 mutations for genomic RNA structure and host microRNA targeting. Int. J. Mol. Sci., 2020, 21(13), 4807.
[http://dx.doi.org/10.3390/ijms21134807] [PMID: 32645951]

Arisan, E.D.; Dart, A.; Grant, G.H.; Arisan, S.; Cuhadaroglu, S.; Lange, S.; Uysal-Onganer, P. The prediction of miRNAs in SARS-CoV-2 genomes: Hsa-miR databases identify 7 key miRs linked to host responses and virus pathogenicity-related KEGG pathways significant for comorbidities. Viruses, 2020, 12(6), 614.
[http://dx.doi.org/10.3390/v12060614] [PMID: 32512929]

Nersisyan, S.; Engibaryan, N.; Gorbonos, A.; Kirdey, K.; Makhonin, A.; Tonevitsky, A. Potential role of cellular miRNAs in coronavirus-host interplay. PeerJ, 2020, 8, e9994.
[http://dx.doi.org/10.7717/peerj.9994] [PMID: 32983652]

Fulzele, S.; Sahay, B.; Yusufu, I.; Lee, T.J.; Sharma, A.; Kolhe, R.; Isales, C.M. COVID-19 virulence in aged patients might be impacted by the host cellular MicroRNAs abundance/profile. Aging Dis., 2020, 11(3), 509-522.
[http://dx.doi.org/10.14336/AD.2020.0428] [PMID: 32489698]

Mishra, P.K.; Tandon, R.; Byrareddy, S.N. Diabetes and COVID-19 risk: An miRNA perspective. Am. J. Physiol. Heart Circ. Physiol., 2020, 319(3), H604-H609.
[http://dx.doi.org/10.1152/ajpheart.00489.2020] [PMID: 32762561]

Chow, J.T-S.; Salmena, L. Prediction and analysis of SARS-CoV-2-targeting microRNA in human lung epithelium. Genes (Basel), 2020, 11(9), 1002.
[http://dx.doi.org/10.3390/genes11091002] [PMID: 32858958]

Li, J.; Dong, X.; Wang, Z.; Wu, J. MicroRNA-1 in cardiac diseases and cancers. Korean J. Physiol. Pharmacol., 2014, 18(5), 359-363.
[http://dx.doi.org/10.4196/kjpp.2014.18.5.359] [PMID: 25352753]

Shang, Q.; Shen, G.; Chen, G.; Zhang, Z.; Yu, X.; Zhao, W.; Zhang, P.; Chen, H.; Tang, K.; Yu, F.; Tang, J.; Liang, D.; Jiang, X.; Ren, H. The emerging role of miR-128 in musculoskeletal diseases. J. Cell. Physiol., 2021, 236(6), 4231-4243.
[http://dx.doi.org/10.1002/jcp.30179] [PMID: 33241566]

Lai, F.W.; Stephenson, K.B.; Mahony, J.; Lichty, B.D. Human coronavirus OC43 nucleocapsid protein binds microRNA 9 and potentiates NF-κB activation. J. Virol., 2014, 88(1), 54-65.
[http://dx.doi.org/10.1128/JVI.02678-13] [PMID: 24109243]

Sabbatinelli, J.; Giuliani, A.; Matacchione, G.; Latini, S.; Laprovitera, N.; Pomponio, G.; Ferrarini, A.; Svegliati Baroni, S.; Pavani, M.; Moretti, M.; Gabrielli, A.; Procopio, A.D.; Ferracin, M.; Bonafè, M.; Olivieri, F. Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients. Mech. Ageing Dev., 2021, 193, 111413.
[http://dx.doi.org/10.1016/j.mad.2020.111413] [PMID: 33307107]

Giuliani, A.; Gaetani, S.; Sorgentoni, G.; Agarbati, S.; Laggetta, M.; Matacchione, G.; Gobbi, M.; Rossi, T.; Galeazzi, R.; Piccinini, G.; Pel-liccioni, G.; Bonfigli, A.R.; Procopio, A.D.; Albertini, M.C.; Sabbatinelli, J.; Olivieri, F.; Fazioli, F. Circulating inflamma-miRs as potential biomarkers of cognitive impairment in patients affected by Alzheimer’s disease. Front. Aging Neurosci., 2021, 13, 647015.
[http://dx.doi.org/10.3389/fnagi.2021.647015] [PMID: 33776746]

Gambardella, J.; Sardu, C.; Morelli, M.B.; Messina, V.; Castellanos, V.; Marfella, R. Exosomal microRNAs drive thrombosis in COVID-19. medRxiv, 2020.
[http://dx.doi.org/10.1101/2020.06.16.20133256]

Delrue, M.; Siguret, V.; Neuwirth, M.; Joly, B.; Beranger, N.; Sène, D.; Chousterman, B.G.; Voicu, S.; Bonnin, P.; Mégarbane, B.; Stépa-nian, A. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients. Br. J. Haematol., 2021, 192(6), 1097-1100.
[http://dx.doi.org/10.1111/bjh.17216] [PMID: 33368196]

Lu, D.; Chatterjee, S.; Xiao, K.; Riedel, I.; Wang, Y.; Foo, R.; Bär, C.; Thum, T. MicroRNAs targeting the SARS-CoV-2 entry receptor ACE2 in cardiomyocytes. J. Mol. Cell. Cardiol., 2020, 148, 46-49.
[http://dx.doi.org/10.1016/j.yjmcc.2020.08.017] [PMID: 32891636]

Gonzalo-Calvo, D.D.; Benítez, I.D.; Pinilla, L.; Carratalá, A.; Moncusí-Moix, A.; Gort-Paniello, C.; Molinero, M.; González, J.; Torres, G.; Bernal, M.; Pico, S.; Almansa, R.; Jorge, N.; Ortega, A.; Bustamante-Munguira, E.; Gómez, J.M.; González-Rivera, M.; Micheloud, D.; Ryan, P.; Martinez, A. Circulating microRNA profiles predict the severity of COVID-19 in hospitalized patients. Transl. Res., 2021, 236, 147-159.
[PMID: 34048985]

Reis, P.P.; Drigo, S.A.; Carvalho, R.F.; Lopez Lapa, R.M.; Felix, T.F.; Patel, D.; Cheng, D.; Pintilie, M.; Liu, G.; Tsao, M.S. Circulating miR-16-5p, miR-92a-3p, and miR-451a in plasma from lung cancer patients: Potential application in early detection and a regulatory role in tumorigenesis pathways. Cancers (Basel), 2020, 12(8), 2071.
[http://dx.doi.org/10.3390/cancers12082071] [PMID: 32726984]

Liu, Q.; Du, J.; Yu, X.; Xu, J.; Huang, F.; Li, X.; Zhang, C.; Li, X.; Chang, J.; Shang, D.; Zhao, Y.; Tian, M.; Lu, H.; Xu, J.; Li, C.; Zhu, H.; Jin, N.; Jiang, C. miRNA-200c-3p is crucial in acute respiratory distress syndrome. Cell Discov., 2017, 3(1), 17021.
[http://dx.doi.org/10.1038/celldisc.2017.21] [PMID: 28690868]

Bertolazzi, G.; Cipollina, C.; Benos, P.V.; Tumminello, M.; Coronnello, C. miR-1207-5p can contribute to dysregulation of inflammatory response in COVID-19 via targeting SARS-CoV-2 RNA. Front. Cell. Infect. Microbiol., 2020, 10, 586592.
[http://dx.doi.org/10.3389/fcimb.2020.586592] [PMID: 33194826]

Huang, K-H.; Lan, Y-T.; Fang, W-L.; Chen, J-H.; Lo, S-S.; Li, A.F-Y.; Chiou, S.H.; Wu, C.W.; Shyr, Y.M. The correlation between miRNA and lymph node metastasis in gastric cancer. BioMed Res. Int., 2015, 2015, 543163.
[http://dx.doi.org/10.1155/2015/543163] [PMID: 25688358]

Ge, X.; Li, W.; Huang, S.; Yin, Z.; Yang, M.; Han, Z.; Han, Z.; Chen, F.; Wang, H.; Lei, P.; Zhang, J. Increased miR-21-3p in injured brain microvascular endothelial cells after traumatic brain injury aggravates blood-brain barrier damage by promoting cellular apoptosis and in-flammation through targeting MAT2B. J. Neurotrauma, 2019, 36(8), 1291-1305.
[http://dx.doi.org/10.1089/neu.2018.5728] [PMID: 29695199]

Lawrie, C.H.; Gal, S.; Dunlop, H.M.; Pushkaran, B.; Liggins, A.P.; Pulford, K.; Banham, A.H.; Pezzella, F.; Boultwood, J.; Wainscoat, J.S.; Hatton, C.S.; Harris, A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lym-phoma. Br. J. Haematol., 2008, 141(5), 672-675.
[http://dx.doi.org/10.1111/j.1365-2141.2008.07077.x] [PMID: 18318758]

Chen, X.; Ba, Y.; Ma, L.; Cai, X.; Yin, Y.; Wang, K.; Guo, J.; Zhang, Y.; Chen, J.; Guo, X.; Li, Q.; Li, X.; Wang, W.; Zhang, Y.; Wang, J.; Jiang, X.; Xiang, Y.; Xu, C.; Zheng, P.; Zhang, J.; Li, R.; Zhang, H.; Shang, X.; Gong, T.; Ning, G.; Wang, J.; Zen, K.; Zhang, J.; Zhang, C.Y. Characterization of microRNAs in serum: A novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res., 2008, 18(10), 997-1006.
[http://dx.doi.org/10.1038/cr.2008.282] [PMID: 18766170]

Wang, C.; Yang, S.; Sun, G.; Tang, X.; Lu, S.; Neyrolles, O.; Gao, Q. Comparative miRNA expression profiles in individuals with latent and active tuberculosis. PLoS One, 2011, 6(10), e25832.
[http://dx.doi.org/10.1371/journal.pone.0025832] [PMID: 22003408]

Garg, A.; Seeliger, B.; Derda, A.A.; Xiao, K.; Gietz, A.; Scherf, K.; Sonnenschein, K.; Pink, I.; Hoeper, M.M.; Welte, T.; Bauersachs, J.; David, S.; Bär, C.; Thum, T. Circulating cardiovascular microRNAs in critically ill COVID-19 patients. Eur. J. Heart Fail., 2021, 23(3), 468-475.
[http://dx.doi.org/10.1002/ejhf.2096] [PMID: 33421274]

Xu, W.; Jiang, X.; Huang, L. RNA Interference Technology. In: Comprehensive Biotechnology; Elsevier, 2019; pp. 560-575.
[http://dx.doi.org/10.1016/B978-0-444-64046-8.00282-2]

Catalanotto, C.; Cogoni, C.; Zardo, G. MicroRNA in control of gene expression: An overview of nuclear functions. Int. J. Mol. Sci., 2016, 17(10), 1712.
[http://dx.doi.org/10.3390/ijms17101712] [PMID: 27754357]

Friedman, R.C.; Farh, K.K-H.; Burge, C.B.; Bartel, D.P. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res., 2009, 19(1), 92-105.
[http://dx.doi.org/10.1101/gr.082701.108] [PMID: 18955434]

Plotnikova, O.; Baranova, A.; Skoblov, M. Comprehensive analysis of human microRNA-mRNA interactome. Front. Genet., 2019, 10, 933.
[http://dx.doi.org/10.3389/fgene.2019.00933] [PMID: 31649721]

Schmidt, M.F. Drug target miRNAs: Chances and challenges. Trends Biotechnol., 2014, 32(11), 578-585.
[http://dx.doi.org/10.1016/j.tibtech.2014.09.002] [PMID: 25304465]

Seto, A.G.; Beatty, X.; Lynch, J.M.; Hermreck, M.; Tetzlaff, M.; Duvic, M.; Jackson, A.L. Cobomarsen, an oligonucleotide inhibitor of miR-155, co-ordinately regulates multiple survival pathways to reduce cellular proliferation and survival in cutaneous T-cell lymphoma. Br. J. Haematol., 2018, 183(3), 428-444.
[http://dx.doi.org/10.1111/bjh.15547] [PMID: 30125933]

Janssen, H.L.A.; Reesink, H.W.; Lawitz, E.J.; Zeuzem, S.; Rodriguez-Torres, M.; Patel, K.; van der Meer, A.J.; Patick, A.K.; Chen, A.; Zhou, Y.; Persson, R.; King, B.D.; Kauppinen, S.; Levin, A.A.; Hodges, M.R. Treatment of HCV infection by targeting microRNA. N. Engl. J. Med., 2013, 368(18), 1685-1694.
[http://dx.doi.org/10.1056/NEJMoa1209026] [PMID: 23534542]

Chakraborty, C.; Sharma, A.R.; Sharma, G.; Lee, S-S. Therapeutic advances of miRNAs: A preclinical and clinical update. J. Adv. Res., 2020, 28, 127-138.
[http://dx.doi.org/10.1016/j.jare.2020.08.012] [PMID: 33364050]

Jopling, C.L.; Yi, M.; Lancaster, A.M.; Lemon, S.M.; Sarnow, P. Modulation of hepatitis C virus RNA abundance by a liver-specific Mi-croRNA. Science, 2005, 309(5740), 1577-1581.
[http://dx.doi.org/10.1126/science.1113329] [PMID: 16141076]

U.S. Food and Drug. Comirnaty and Pfizer-BioNTech COVID-19 Vaccine. Available from: https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/pfizer-biontech-covid-19-vaccine

WHO. Status of COVID-19 Vaccines within WHO EUL/PQ evaluation process. Available from: https://extranet.who.int/pqweb/sites/default/files/documents/Status_COVID_VAX_20Oct2021.pdf

Walsh, E.E. Frenck, R.W., Jr; Falsey, A.R.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Neuzil, K.; Mulligan, M.J.; Bailey, R.; Swanson, K.A.; Li, P.; Koury, K.; Kalina, W.; Cooper, D.; Fontes-Garfias, C.; Shi, P.Y.; Türeci, Ö.; Tompkins, K.R.; Lyke, K.E.; Raabe, V.; Dormitzer, P.R.; Jansen, K.U.; Şahin, U.; Gruber, W.C. Safety and immunogenicity of two RNA-based covid-19 vaccine candidates. N. Engl. J. Med., 2020, 383(25), 2439-2450.
[http://dx.doi.org/10.1056/NEJMoa2027906] [PMID: 33053279]

Costanzo, M.; De Giglio, M.A.R.; Roviello, G.N. Anti-coronavirus vaccines: Past investigations on SARS-CoV-1 and MERS-CoV, the approved vaccines from BioNTech/Pfizer, Moderna, Oxford/AstraZeneca and others under development against SARS-CoV-2 infection. Curr. Med. Chem., 2022, 29(1), 4-18.
[PMID: 34355678]

Study to Describe the Safety, Tolerability, Immunogenicity, and Efficacy of RNA Vaccine Candidates against COVID-19 in Healthy Individuals. Available from: https://clinicaltrials.gov/ct2/show/NCT04368728

Pfizer Says Experimental COVID-19 Vaccine Is More Than 90% Effective. Available from: https://www.npr.org/sections/health-shots/2020/11/09/933006651/pfizer-says-experimental-covid-19-vaccine-is-more-than-90-effective

Folegatti, P.M.; Ewer, K.J.; Aley, P.K.; Angus, B.; Becker, S.; Belij-Rammerstorfer, S.; Bellamy, D.; Bibi, S.; Bittaye, M.; Clutterbuck, E.A.; Dold, C.; Faust, S.N.; Finn, A.; Flaxman, A.L.; Hallis, B.; Heath, P.; Jenkin, D.; Lazarus, R.; Makinson, R.; Minassian, A.M.; Pollock, K.M.; Ramasamy, M.; Robinson, H.; Snape, M.; Tarrant, R.; Voysey, M.; Green, C.; Douglas, A.D.; Hill, A.V.S.; Lambe, T.; Gilbert, S.C.; Pollard, A.J.; Aboagye, J.; Adams, K.; Ali, A.; Allen, E.; Allison, J.L.; Anslow, R.; Arbe-Barnes, E.H.; Babbage, G.; Baillie, K.; Baker, M.; Baker, N.; Baker, P.; Baleanu, I.; Ballaminut, J.; Barnes, E.; Barrett, J.; Bates, L.; Batten, A.; Beadon, K.; Beckley, R.; Berrie, E.; Berry, L.; Beveridge, A.; Bewley, K.R.; Bijker, E.M.; Bingham, T.; Blackwell, L.; Blundell, C.L.; Bolam, E.; Boland, E.; Borthwick, N.; Bower, T.; Boyd, A.; Brenner, T.; Bright, P.D.; Brown-O’Sullivan, C.; Brunt, E.; Burbage, J.; Burge, S.; Buttigieg, K.R.; Byard, N.; Cabera Puig, I.; Cal-vert, A.; Camara, S.; Cao, M.; Cappuccini, F.; Carr, M.; Carroll, M.W.; Carter, V.; Cathie, K.; Challis, R.J.; Charlton, S.; Chelysheva, I.; Cho, J-S.; Cicconi, P.; Cifuentes, L.; Clark, H.; Clark, E.; Cole, T.; Colin-Jones, R.; Conlon, C.P.; Cook, A.; Coombes, N.S.; Cooper, R.; Cosgrove, C.A.; Coy, K.; Crocker, W.E.M.; Cunningham, C.J.; Damratoski, B.E.; Dando, L.; Datoo, M.S.; Davies, H.; De Graaf, H.; De-missie, T.; Di Maso, C.; Dietrich, I.; Dong, T.; Donnellan, F.R.; Douglas, N.; Downing, C.; Drake, J.; Drake-Brockman, R.; Drury, R.E.; Dunachie, S.J.; Edwards, N.J.; Edwards, F.D.L.; Edwards, C.J.; Elias, S.C.; Elmore, M.J.; Emary, K.R.W.; English, M.R.; Fagerbrink, S.; Felle, S.; Feng, S.; Field, S.; Fixmer, C.; Fletcher, C.; Ford, K.J.; Fowler, J.; Fox, P.; Francis, E.; Frater, J.; Furze, J.; Fuskova, M.; Galiza, E.; Gbesemete, D.; Gilbride, C.; Godwin, K.; Gorini, G.; Goulston, L.; Grabau, C.; Gracie, L.; Gray, Z.; Guthrie, L.B.; Hackett, M.; Halwe, S.; Hamilton, E.; Hamlyn, J.; Hanumunthadu, B.; Harding, I.; Harris, S.A.; Harris, A.; Harrison, D.; Harrison, C.; Hart, T.C.; Haskell, L.; Hawkins, S.; Head, I.; Henry, J.A.; Hill, J.; Hodgson, S.H.C.; Hou, M.M.; Howe, E.; Howell, N.; Hutlin, C.; Ikram, S.; Isitt, C.; Iveson, P.; Jackson, S.; Jackson, F.; James, S.W.; Jenkins, M.; Jones, E.; Jones, K.; Jones, C.E.; Jones, B.; Kailath, R.; Karampatsas, K.; Keen, J.; Kelly, S.; Kelly, D.; Kerr, D.; Kerridge, S.; Khan, L.; Khan, U.; Killen, A.; Kinch, J.; King, T.B.; King, L.; King, J.; Kingham-Page, L.; Klenerman, P.; Knapper, F.; Knight, J.C.; Knott, D.; Koleva, S.; Kupke, A.; Larkworthy, C.W.; Larwood, J.P.J.; Laskey, A.; Lawrie, A.M.; Lee, A.; Ngan Lee, K.Y.; Lees, E.A.; Legge, H.; Lelliott, A.; Lemm, N-M.; Lias, A.M.; Linder, A.; Lipworth, S.; Liu, X.; Liu, S.; Lopez Ramon, R.; Lwin, M.; Mabesa, F.; Madhavan, M.; Mallett, G.; Mansatta, K.; Marcal, I.; Marinou, S.; Marlow, E.; Marshall, J.L.; Martin, J.; McEwan, J.; McInroy, L.; Meddaugh, G.; Mentzer, A.J.; Mirtorabi, N.; Moore, M.; Moran, E.; Morey, E.; Morgan, V.; Morris, S.J.; Morri-son, H.; Morshead, G.; Morter, R.; Mujadidi, Y.F.; Muller, J.; Munera-Huertas, T.; Munro, C.; Munro, A.; Murphy, S.; Munster, V.J.; Mweu, P.; Noé, A.; Nugent, F.L.; Nuthall, E.; O’Brien, K.; O’Connor, D.; Oguti, B.; Oliver, J.L.; Oliveira, C.; O’Reilly, P.J.; Osborn, M.; Osborne, P.; Owen, C.; Owens, D.; Owino, N.; Pacurar, M.; Parker, K.; Parracho, H.; Patrick-Smith, M.; Payne, V.; Pearce, J.; Peng, Y.; Peralta Alvarez, M.P.; Perring, J.; Pfafferott, K.; Pipini, D.; Plested, E.; Pluess-Hall, H.; Pollock, K.; Poulton, I.; Presland, L.; Provstgaard-Morys, S.; Pulido, D.; Radia, K.; Ramos Lopez, F.; Rand, J.; Ratcliffe, H.; Rawlinson, T.; Rhead, S.; Riddell, A.; Ritchie, A.J.; Roberts, H.; Robson, J.; Roche, S.; Rohde, C.; Rollier, C.S.; Romani, R.; Rudiansyah, I.; Saich, S.; Sajjad, S.; Salvador, S.; Sanchez Riera, L.; Sanders, H.; Sanders, K.; Sapaun, S.; Sayce, C.; Schofield, E.; Screaton, G.; Selby, B.; Semple, C.; Sharpe, H.R.; Shaik, I.; Shea, A.; Shelton, H.; Silk, S.; Silva-Reyes, L.; Skelly, D.T.; Smee, H.; Smith, C.C.; Smith, D.J.; Song, R.; Spencer, A.J.; Stafford, E.; Steele, A.; Stefanova, E.; Stockdale, L.; Szigeti, A.; Tahiri-Alaoui, A.; Tait, M.; Talbot, H.; Tanner, R.; Taylor, I.J.; Taylor, V.; Te Water Naude, R.; Thakur, N.; Themistocleous, Y.; Themistocleous, A.; Thomas, M.; Thomas, T.M.; Thompson, A.; Thomson-Hill, S.; Tomlins, J.; Tonks, S.; Towner, J.; Tran, N.; Tree, J.A.; Truby, A.; Turkentine, K.; Turner, C.; Turner, N.; Turner, S.; Tuthill, T.; Ulaszewska, M.; Varughese, R.; Van Doremalen, N.; Veighey, K.; Verheul, M.K.; Vichos, I.; Vitale, E.; Walker, L.; Watson, M.E.E.; Welham, B.; Wheat, J.; White, C.; White, R.; Worth, A.T.; Wright, D.; Wright, S.; Yao, X.L.; Yau, Y. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: A preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet, 2020, 396(10249), 467-478.
[http://dx.doi.org/10.1016/S0140-6736(20)31604-4] [PMID: 32702298]

Mendonça, S.A.; Lorincz, R.; Boucher, P.; Curiel, D.T. Adenoviral vector vaccine platforms in the SARS-CoV-2 pandemic. NPJ Vaccines, 2021, 6(1), 97.
[http://dx.doi.org/10.1038/s41541-021-00356-x] [PMID: 34354082]

New Drug Approvals. Available from: https://newdrugapprovals.org/2021/03/21/moderna-covid-19-vaccine-mrna-1273/

El Sahly, H.M.; Baden, L.R.; Essink, B.; Doblecki-Lewis, S.; Martin, J.M.; Anderson, E.J.; Campbell, T.B.; Clark, J.; Jackson, L.A.; Fichtenbaum, C.J.; Zervos, M.; Rankin, B.; Eder, F.; Feldman, G.; Kennelly, C.; Han-Conrad, L.; Levin, M.; Neuzil, K.M.; Corey, L.; Gil-bert, P.; Janes, H.; Follmann, D.; Marovich, M.; Polakowski, L.; Mascola, J.R.; Ledgerwood, J.E.; Graham, B.S.; August, A.; Clouting, H.; Deng, W.; Han, S.; Leav, B.; Manzo, D.; Pajon, R.; Schödel, F.; Tomassini, J.E.; Zhou, H.; Miller, J. Efficacy of the mRNA-1273 SARS-CoV-2 vaccine at completion of blinded phase. N. Engl. J. Med., 2021, 385(19), 1774-1785.
[http://dx.doi.org/10.1056/NEJMoa2113017] [PMID: 34551225]

Leiden developed Covid-19 vaccine submitted to EMA for approval. Available from: https://nltimes.nl/2021/02/16/leiden-developed-covid-19-vaccine-submitted-ema-approval

Bos, R.; Rutten, L.; van der Lubbe, J.E.M.; Bakkers, M.J.G.; Hardenberg, G.; Wegmann, F.; Zuijdgeest, D.; de Wilde, A.H.; Koornneef, A.; Verwilligen, A.; van Manen, D.; Kwaks, T.; Vogels, R.; Dalebout, T.J.; Myeni, S.K.; Kikkert, M.; Snijder, E.J.; Li, Z.; Barouch, D.H.; Vel-linga, J.; Langedijk, J.P.M.; Zahn, R.C.; Custers, J.; Schuitemaker, H. Ad26 vector-based COVID-19 vaccine encoding a prefusion-stabilized SARS-CoV-2 spike immunogen induces potent humoral and cellular immune responses. NPJ Vaccines, 2020, 5(1), 91.
[http://dx.doi.org/10.1038/s41541-020-00243-x] [PMID: 33083026]

Mallapaty, S. China’s COVID vaccines are going global - but questions remain. Nature, 2021, 593(7858), 178-179.
[http://dx.doi.org/10.1038/d41586-021-01146-0] [PMID: 33948031]

Zhang, Y.; Zeng, G.; Pan, H.; Li, C.; Hu, Y.; Chu, K.; Han, W.; Chen, Z.; Tang, R.; Yin, W.; Chen, X.; Hu, Y.; Liu, X.; Jiang, C.; Li, J.; Yang, M.; Song, Y.; Wang, X.; Gao, Q.; Zhu, F. Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: A randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet Infect. Dis., 2021, 21(2), 181-192.
[http://dx.doi.org/10.1016/S1473-3099(20)30843-4] [PMID: 33217362]

Gao, Q.; Bao, L.; Mao, H.; Wang, L.; Xu, K.; Yang, M.; Li, Y.; Zhu, L.; Wang, N.; Lv, Z.; Gao, H.; Ge, X.; Kan, B.; Hu, Y.; Liu, J.; Cai, F.; Jiang, D.; Yin, Y.; Qin, C.; Li, J.; Gong, X.; Lou, X.; Shi, W.; Wu, D.; Zhang, H.; Zhu, L.; Deng, W.; Li, Y.; Lu, J.; Li, C.; Wang, X.; Yin, W.; Zhang, Y.; Qin, C. Development of an inactivated vaccine candidate for SARS-CoV-2. Science, 2020, 369(6499), 77-81.
[http://dx.doi.org/10.1126/science.abc1932] [PMID: 32376603]

Covaxin: India’s homegrown Covid-19 vaccine has 78% efficacy against symptomatic infections, developer says - CNN Available from: https://edition.cnn.com/2021/07/03/india/bharat-biotech-covaxin-efficacy-intl-hnk/index.html Accessed on 2021 Nov 10.

Ella, R.; Reddy, S.; Blackwelder, W.; Potdar, V.; Yadav, P.; Sarangi, V. Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS-CoV-2 vaccine (BBV152): A, double-blind, randomised, controlled phase 3 trial. medRxiv, 2021.
[http://dx.doi.org/10.1101/2021.06.30.21259439]

Polack, F.P. Thomas, S.J.; Kitchin, N.; Absalon, J.; Gurtman, A.; Lockhart, S.; Perez, J.L.; Pérez Marc, G.; Moreira, E.D.; Zerbini, C.; Bailey, R.; Swanson, K.A.; Roychoudhury, S.; Koury, K.; Li, P.; Kalina, W.V.; Cooper, D.; Frenck, R.W., Jr.; Hammitt, L.L.; Türeci, Ö.; Nell, H.; Schaefer, A.; Ünal, S.; Tresnan, D.B.; Mather, S.; Dormitzer, P.R.; Şahin, U.; Jansen, K.U.; Gruber, W.C. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med., 2020, 383(27), 2603-2615.
[http://dx.doi.org/10.1056/NEJMoa2034577] [PMID: 33301246]

Voysey, M.; Clemens, S.A.C.; Madhi, S.A.; Weckx, L.Y.; Folegatti, P.M.; Aley, P.K.; Angus, B.; Baillie, V.L.; Barnabas, S.L.; Bhorat, Q.E.; Bibi, S.; Briner, C.; Cicconi, P.; Collins, A.M.; Colin-Jones, R.; Cutland, C.L.; Darton, T.C.; Dheda, K.; Duncan, C.J.A.; Emary, K.R.W.; Ewer, K.J.; Fairlie, L.; Faust, S.N.; Feng, S.; Ferreira, D.M.; Finn, A.; Goodman, A.L.; Green, C.M.; Green, C.A.; Heath, P.T.; Hill, C.; Hill, H.; Hirsch, I.; Hodgson, S.H.C.; Izu, A.; Jackson, S.; Jenkin, D.; Joe, C.C.D.; Kerridge, S.; Koen, A.; Kwatra, G.; Lazarus, R.; Lawrie, A.M.; Lelliott, A.; Libri, V.; Lillie, P.J.; Mallory, R.; Mendes, A.V.A.; Milan, E.P.; Minassian, A.M.; McGregor, A.; Morrison, H.; Muja-didi, Y.F.; Nana, A.; O’Reilly, P.J.; Padayachee, S.D.; Pittella, A.; Plested, E.; Pollock, K.M.; Ramasamy, M.N.; Rhead, S.; Schwarzbold, A.V.; Singh, N.; Smith, A.; Song, R.; Snape, M.D.; Sprinz, E.; Sutherland, R.K.; Tarrant, R.; Thomson, E.C.; Török, M.E.; Toshner, M.; Turner, D.P.J.; Vekemans, J.; Villafana, T.L.; Watson, M.E.E.; Williams, C.J.; Douglas, A.D.; Hill, A.V.S.; Lambe, T.; Gilbert, S.C.; Pol-lard, A.J.; Aban, M.; Abayomi, F.; Abeyskera, K.; Aboagye, J.; Adam, M.; Adams, K.; Adamson, J.; Adelaja, Y.A.; Adewetan, G.; Adlou, S.; Ahmed, K.; Akhalwaya, Y.; Akhalwaya, S.; Alcock, A.; Ali, A.; Allen, E.R.; Allen, L.; Almeida, T.C.D.S.C.; Alves, M.P.S.; Amorim, F.; Andritsou, F.; Anslow, R.; Appleby, M.; Arbe-Barnes, E.H.; Ariaans, M.P.; Arns, B.; Arruda, L.; Azi, P.; Azi, L.; Babbage, G.; Bailey, C.; Baker, K.F.; Baker, M.; Baker, N.; Baker, P.; Baldwin, L.; Baleanu, I.; Bandeira, D.; Bara, A.; Barbosa, M.A.S.; Barker, D.; Barlow, G.D.; Barnes, E.; Barr, A.S.; Barrett, J.R.; Barrett, J.; Bates, L.; Batten, A.; Beadon, K.; Beales, E.; Beckley, R.; Belij-Rammerstorfer, S.; Bell, J.; Bellamy, D.; Bellei, N.; Belton, S.; Berg, A.; Bermejo, L.; Berrie, E.; Berry, L.; Berzenyi, D.; Beveridge, A.; Bewley, K.R.; Bexhell, H.; Bhi-kha, S.; Bhorat, A.E.; Bhorat, Z.E.; Bijker, E.; Birch, G.; Birch, S.; Bird, A.; Bird, O.; Bisnauthsing, K.; Bittaye, M.; Blackstone, K.; Black-well, L.; Bletchly, H.; Blundell, C.L.; Blundell, S.R.; Bodalia, P.; Boettger, B.C.; Bolam, E.; Boland, E.; Bormans, D.; Borthwick, N.; Bowring, F.; Boyd, A.; Bradley, P.; Brenner, T.; Brown, P.; Brown, C.; Brown-O’Sullivan, C.; Bruce, S.; Brunt, E.; Buchan, R.; Budd, W.; Bulbulia, Y.A.; Bull, M.; Burbage, J.; Burhan, H.; Burn, A.; Buttigieg, K.R.; Byard, N.; Cabera Puig, I.; Calderon, G.; Calvert, A.; Camara, S.; Cao, M.; Cappuccini, F.; Cardoso, J.R.; Carr, M.; Carroll, M.W.; Carson-Stevens, A.; Carvalho, Y.M.; Carvalho, J.A.M.; Casey, H.R.; Cashen, P.; Castro, T.; Castro, L.C.; Cathie, K.; Cavey, A.; Cerbino-Neto, J.; Chadwick, J.; Chapman, D.; Charlton, S.; Chelysheva, I.; Chester, O.; Chita, S.; Cho, J-S.; Cifuentes, L.; Clark, E.; Clark, M.; Clarke, A.; Clutterbuck, E.A.; Collins, S.L.K.; Conlon, C.P.; Connarty, S.; Coombes, N.; Cooper, C.; Cooper, R.; Cornelissen, L.; Corrah, T.; Cosgrove, C.; Cox, T.; Crocker, W.E.M.; Crosbie, S.; Cullen, L.; Cul-len, D.; Cunha, D.R.M.F.; Cunningham, C.; Cuthbertson, F.C.; Da Guarda, S.N.F.; da Silva, L.P.; Damratoski, B.E.; Danos, Z.; Dantas, M.T.D.C.; Darroch, P.; Datoo, M.S.; Datta, C.; Davids, M.; Davies, S.L.; Davies, H.; Davis, E.; Davis, J.; Davis, J.; De Nobrega, M.M.D.; De Oliveira Kalid, L.M.; Dearlove, D.; Demissie, T.; Desai, A.; Di Marco, S.; Di Maso, C.; Dinelli, M.I.S.; Dinesh, T.; Docksey, C.; Dold, C.; Dong, T.; Donnellan, F.R.; Dos Santos, T.; dos Santos, T.G.; Dos Santos, E.P.; Douglas, N.; Downing, C.; Drake, J.; Drake-Brockman, R.; Driver, K.; Drury, R.; Dunachie, S.J.; Durham, B.S.; Dutra, L.; Easom, N.J.W.; van Eck, S.; Edwards, M.; Edwards, N.J.; El Muhanna, O.M.; Elias, S.C.; Elmore, M.; English, M.; Esmail, A.; Essack, Y.M.; Farmer, E.; Farooq, M.; Farrar, M.; Farrugia, L.; Faulkner, B.; Fedo-syuk, S.; Felle, S.; Feng, S.; Ferreira Da Silva, C.; Field, S.; Fisher, R.; Flaxman, A.; Fletcher, J.; Fofie, H.; Fok, H.; Ford, K.J.; Fowler, J.; Fraiman, P.H.A.; Francis, E.; Franco, M.M.; Frater, J.; Freire, M.S.M.; Fry, S.H.; Fudge, S.; Furze, J.; Fuskova, M.; Galian-Rubio, P.; Gali-za, E.; Garlant, H.; Gavrila, M.; Geddes, A.; Gibbons, K.A.; Gilbride, C.; Gill, H.; Glynn, S.; Godwin, K.; Gokani, K.; Goldoni, U.C.; Gon-calves, M.; Gonzalez, I.G.S.; Goodwin, J.; Goondiwala, A.; Gordon-Quayle, K.; Gorini, G.; Grab, J.; Gracie, L.; Greenland, M.; Green-wood, N.; Greffrath, J.; Groenewald, M.M.; Grossi, L.; Gupta, G.; Hackett, M.; Hallis, B.; Hamaluba, M.; Hamilton, E.; Hamlyn, J.; Ham-mersley, D.; Hanrath, A.T.; Hanumunthadu, B.; Harris, S.A.; Harris, C.; Harris, T.; Harrison, T.D.; Harrison, D.; Hart, T.C.; Hartnell, B.; Hassan, S.; Haughney, J.; Hawkins, S.; Hay, J.; Head, I.; Henry, J.; Hermosin Herrera, M.; Hettle, D.B.; Hill, J.; Hodges, G.; Horne, E.; Hou, M.M.; Houlihan, C.; Howe, E.; Howell, N.; Humphreys, J.; Humphries, H.E.; Hurley, K.; Huson, C.; Hyder-Wright, A.; Hyams, C.; Ikram, S.; Ishwarbhai, A.; Ivan, M.; Iveson, P.; Iyer, V.; Jackson, F.; De Jager, J.; Jaumdally, S.; Jeffers, H.; Jesudason, N.; Jones, B.; Jones, K.; Jones, E.; Jones, C.; Jorge, M.R.; Jose, A.; Joshi, A.; Júnior, E.A.M.S.; Kadziola, J.; Kailath, R.; Kana, F.; Karampatsas, K.; Kasanyinga, M.; Keen, J.; Kelly, E.J.; Kelly, D.M.; Kelly, D.; Kelly, S.; Kerr, D.; Kfouri, R.Á.; Khan, L.; Khozoee, B.; Kidd, S.; Killen, A.; Kinch, J.; Kinch, P.; King, L.D.W.; King, T.B.; Kingham, L.; Klenerman, P.; Knapper, F.; Knight, J.C.; Knott, D.; Koleva, S.; Lang, M.; Lang, G.; Larkworthy, C.W.; Larwood, J.P.J.; Law, R.; Lazarus, E.M.; Leach, A.; Lees, E.A.; Lemm, N-M.; Lessa, A.; Leung, S.; Li, Y.; Lias, A.M.; Liatsikos, K.; Linder, A.; Lipworth, S.; Liu, S.; Liu, X.; Lloyd, A.; Lloyd, S.; Loew, L.; Lopez Ramon, R.; Lora, L.; Lowthorpe, V.; Luz, K.; MacDonald, J.C.; MacGregor, G.; Madhavan, M.; Mainwaring, D.O.; Makambwa, E.; Makinson, R.; Malahleha, M.; Malamatsho, R.; Mallett, G.; Mansatta, K.; Maoko, T.; Mapetla, K.; Marchevsky, N.G.; Marinou, S.; Marlow, E.; Marques, G.N.; Mar-riott, P.; Marshall, R.P.; Marshall, J.L.; Martins, F.J.; Masenya, M.; Masilela, M.; Masters, S.K.; Mathew, M.; Matlebjane, H.; Matshidiso, K.; Mazur, O.; Mazzella, A.; McCaughan, H.; McEwan, J.; McGlashan, J.; McInroy, L.; McIntyre, Z.; McLenaghan, D.; McRobert, N.; McSwiggan, S.; Megson, C.; Mehdipour, S.; Meijs, W.; Mendonça, R.N.Á.; Mentzer, A.J.; Mirtorabi, N.; Mitton, C.; Mnyakeni, S.; Moghaddas, F.; Molapo, K.; Moloi, M.; Moore, M.; Moraes-Pinto, M.I.; Moran, M.; Morey, E.; Morgans, R.; Morris, S.; Morris, S.; Mor-ris, H.C.; Morselli, F.; Morshead, G.; Morter, R.; Mottal, L.; Moultrie, A.; Moya, N.; Mpelembue, M.; Msomi, S.; Mugodi, Y.; Mukho-padhyay, E.; Muller, J.; Munro, A.; Munro, C.; Murphy, S.; Mweu, P.; Myasaki, C.H.; Naik, G.; Naker, K.; Nastouli, E.; Nazir, A.; Ndlovu, B.; Neffa, F.; Njenga, C.; Noal, H.; Noé, A.; Novaes, G.; Nugent, F.L.; Nunes, G.; O’Brien, K.; O’Connor, D.; Odam, M.; Oelofse, S.; Oguti, B.; Olchawski, V.; Oldfield, N.J.; Oliveira, M.G.; Oliveira, C.; Oosthuizen, A.; O’Reilly, P.; Osborne, P.; Owen, D.R.J.; Owen, L.; Owens, D.; Owino, N.; Pacurar, M.; Paiva, B.V.B.; Palhares, E.M.F.; Palmer, S.; Parkinson, S.; Parracho, H.M.R.T.; Parsons, K.; Patel, D.; Patel, B.; Patel, F.; Patel, K.; Patrick-Smith, M.; Payne, R.O.; Peng, Y.; Penn, E.J.; Pennington, A.; Peralta Alvarez, M.P.; Perring, J.; Perry, N.; Perumal, R.; Petkar, S.; Philip, T.; Phillips, D.J.; Phillips, J.; Phohu, M.K.; Pickup, L.; Pieterse, S.; Piper, J.; Pipini, D.; Plank, M.; Du Plessis, J.; Pollard, S.; Pooley, J.; Pooran, A.; Poulton, I.; Powers, C.; Presa, F.B.; Price, D.A.; Price, V.; Primeira, M.; Proud, P.C. Provst-gaard-Morys, S.; Pueschel, S.; Pulido, D.; Quaid, S.; Rabara, R.; Radford, A.; Radia, K.; Rajapaska, D.; Rajeswaran, T.; Ramos, A.S.F.; Ramos Lopez, F.; Rampling, T.; Rand, J.; Ratcliffe, H.; Rawlinson, T.; Rea, D.; Rees, B.; Reiné, J.; Resuello-Dauti, M.; Reyes Pabon, E.; Ribiero, C.M.; Ricamara, M.; Richter, A.; Ritchie, N.; Ritchie, A.J.; Robbins, A.J.; Roberts, H.; Robinson, R.E.; Robinson, H.; Rocchetti, T.T.; Rocha, B.P.; Roche, S.; Rollier, C.; Rose, L.; Ross Russell, A.L.; Rossouw, L.; Royal, S.; Rudiansyah, I.; Ruiz, S.; Saich, S.; Sala, C.; Sale, J.; Salman, A.M.; Salvador, N.; Salvador, S.; Sampaio, M.; Samson, A.D.; Sanchez-Gonzalez, A.; Sanders, H.; Sanders, K.; Santos, E.; Santos Guerra, M.F.S.; Satti, I.; Saunders, J.E.; Saunders, C.; Sayed, A.; Schim van der Loeff, I.; Schmid, A.B.; Schofield, E.; Screaton, G.; Seddiqi, S.; Segireddy, R.R.; Senger, R.; Serrano, S.; Shah, R.; Shaik, I.; Sharpe, H.E.; Sharrocks, K.; Shaw, R.; Shea, A.; Shepherd, A.; Shepherd, J.G.; Shiham, F.; Sidhom, E.; Silk, S.E.; da Silva Moraes, A.C.; Silva-Junior, G.; Silva-Reyes, L.; Silveira, A.D.; Silveira, M.B.V.; Sinha, J.; Skelly, D.T.; Smith, D.C.; Smith, N.; Smith, H.E.; Smith, D.J.; Smith, C.C.; Soares, A.; Soares, T.; Solórzano, C.; Sorio, G.L.; Sorley, K.; Sosa-Rodriguez, T.; Souza, C.M.C.D.L.; Souza, B.S.D.F.; Souza, A.R.; Spencer, A.J.; Spina, F.; Spoors, L.; Stafford, L.; Stamford, I.; Starinskij, I.; Stein, R.; Steven, J.; Stockdale, L.; Stockwell, L.V.; Strickland, L.H.; Stuart, A.C.; Sturdy, A.; Sutton, N.; Szigeti, A.; Tahiri-Alaoui, A.; Tanner, R.; Taoushanis, C.; Tarr, A.W.; Taylor, K.; Taylor, U.; Taylor, I.J.; Taylor, J.; te Water Naude, R.; Themis-tocleous, Y.; Themistocleous, A.; Thomas, M.; Thomas, K.; Thomas, T.M.; Thombrayil, A.; Thompson, F.; Thompson, A.; Thompson, K.; Thompson, A.; Thomson, J.; Thornton-Jones, V.; Tighe, P.J.; Tinoco, L.A.; Tiongson, G.; Tladinyane, B.; Tomasicchio, M.; Tomic, A.; Tonks, S.; Towner, J.; Tran, N.; Tree, J.; Trillana, G.; Trinham, C.; Trivett, R.; Truby, A.; Tsheko, B.L.; Turabi, A.; Turner, R.; Turner, C.; Ulaszewska, M.; Underwood, B.R.; Varughese, R.; Verbart, D.; Verheul, M.; Vichos, I.; Vieira, T.; Waddington, C.S.; Walker, L.; Wal-lis, E.; Wand, M.; Warbick, D.; Wardell, T.; Warimwe, G.; Warren, S.C.; Watkins, B.; Watson, E.; Webb, S.; Webb-Bridges, A.; Webster, A.; Welch, J.; Wells, J.; West, A.; White, C.; White, R.; Williams, P.; Williams, R.L.; Winslow, R.; Woodyer, M.; Worth, A.T.; Wright, D.; Wroblewska, M.; Yao, A.; Zimmer, R.; Zizi, D.; Zuidewind, P. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: An interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet, 2021, 397(10269), 99-111.
[http://dx.doi.org/10.1016/S0140-6736(20)32661-1] [PMID: 33306989]

Baden, L.R.; El Sahly, H.M.; Essink, B.; Kotloff, K.; Frey, S.; Novak, R.; Diemert, D.; Spector, S.A.; Rouphael, N.; Creech, C.B.; McGet-tigan, J.; Khetan, S.; Segall, N.; Solis, J.; Brosz, A.; Fierro, C.; Schwartz, H.; Neuzil, K.; Corey, L.; Gilbert, P.; Janes, H.; Follmann, D.; Ma-rovich, M.; Mascola, J.; Polakowski, L.; Ledgerwood, J.; Graham, B.S.; Bennett, H.; Pajon, R.; Knightly, C.; Leav, B.; Deng, W.; Zhou, H.; Han, S.; Ivarsson, M.; Miller, J.; Zaks, T. Efficacy and safety of the mRNA-1273 SARS-CoV-2 Vaccine. N. Engl. J. Med., 2021, 384(5), 403-416.
[http://dx.doi.org/10.1056/NEJMoa2035389] [PMID: 33378609]

Evidence Assessment: Sinopharm/BBIBP COVID-19 vaccine. Available from: https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/2_sage29apr2021_critical-evidence_sinopharm.pdf Accessed on 2021 Nov 10.

Zheng, B.; Peng, W.; Guo, M.; Huang, M.; Gu, Y.; Wang, T. Inhalable nanovaccine with biomimetic coronavirus structure to trigger muco-sal immunity of respiratory tract against COVID-19. Chem. Eng. J., 2021, 418, 129392.
[PMID: 33762883]

Höbel, S.; Aigner, A. Polyethylenimines for siRNA and miRNA delivery in vivo. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 2013, 5(5), 484-501.
[http://dx.doi.org/10.1002/wnan.1228] [PMID: 23720168]

Ghini, F.; Rubolino, C.; Climent, M.; Simeone, I.; Marzi, M.J.; Nicassio, F. Endogenous transcripts control miRNA levels and activity in mammalian cells by target-directed miRNA degradation. Nat. Commun., 2018, 9(1), 3119.
[http://dx.doi.org/10.1038/s41467-018-05182-9] [PMID: 30087332]

Lam, J.K-W.; Liang, W.; Chan, H-K. Pulmonary delivery of therapeutic siRNA. Adv. Drug Deliv. Rev., 2012, 64(1), 1-15.
[http://dx.doi.org/10.1016/j.addr.2011.02.006] [PMID: 21356260]

Schlosser, K.; Taha, M.; Stewart, D.J. Systematic assessment of strategies for lung-targeted delivery of MicroRNA mimics. Theranostics, 2018, 8(5), 1213-1226.
[http://dx.doi.org/10.7150/thno.22912] [PMID: 29507615]